A study of SAR444245 combined with other anticancer therapies for the treatment of participants with HNSCC (Master Protocol) (Pegathor Head and Neck 204)

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Argentina, Buenos Aires	Buenos Aires, Argentina, 1012
Canada, Quebec	Montreal, Quebec, Canada, H4A 3J1
Chile, Reg Metropolitana de Santiago	Santiago, Reg Metropolitana de Santiago, Chile, 7500921
Chile, Valparaíso	Vina del Mar, Valparaíso, Chile, 2540488
CHILE	Temuco, CHILE, 4800827
CHILE, Reg Metropolitana de Santiago	Santiago, Reg Metropolitana de Santiago, CHILE, 8420383
France	Bordeaux, France, 33075
France	Lyon, France, 69008
France	Paris, France, 75015
France	Strasbourg, France, 67033
France	Villejuif, France, 94800
Germany	Berlin, Germany, 12200
Italy, Brescia	Brescia, Italy, 25123
Korea, Republic of, Seoul-teukbyeolsi	Seoul, Seoul-teukbyeolsi, Korea, Republic of, 06351
Korea, Republic of, Seoul-teukbyeolsi	Seoul, Seoul-teukbyeolsi, Korea, Republic of, 05505
Netherlands	Amsterdam, Netherlands, 1066
Netherlands	Nijmegen, Netherlands, 6500 HB
Spain, Barcelona [Barcelona]	Barcelona, Barcelona [Barcelona], Spain, 08035
Spain, Barcelona [Barcelona]	Barcelona, Barcelona [Barcelona], Spain, 08036
Spain, Madrid, Comunidad de	Madrid, Madrid, Comunidad de, Spain, 28046
Spain, Madrid, Comunidad de	Madrid, Madrid, Comunidad de, Spain, 28040
Taiwan	Tainan, Taiwan, 704
United States, California	Duarte, California, United States, 91010
United States, Colorado	Aurora, Colorado, United States, 80045
United States, Michigan	Ann Arbor, Michigan, United States, 48109
UNITED STATES, Pennsylvania	Philadelphia, Pennsylvania, UNITED STATES, 19107
UNITED STATES, Washington	Seattle, Washington, UNITED STATES, 98115